HEINS MARROQUIN, U., SINGH, R., PERATHONER, S., GAVOTTO, F., Merino Ruiz, C., PATRASKAKI, M., Gomez-Giro, G., Kleine Borgmann, F., Meyer, M., Carpentier, A., WARMOES, M. O., Jäger, C., MITTELBRONN, M., SCHWAMBORN, J. C., Cordero-Maldonado, M. L., CRAWFORD, A., SCHYMANSKI, E., & LINSTER, C. (March 2024). CLN3 deficiency leads to neurological and metabolic perturbations during early development. Life Science Alliance, 7 (3). doi:10.26508/lsa.202302057 Peer Reviewed verified by ORBi |
HEINS MARROQUIN, U., SINGH, R., PERATHONER, S., GAVOTTO, F., Ruiz, C. M., PATRASKAKI, M., Gomez-Giro, G., Borgmann, F. K., Meyer, M., Carpentier, A., WARMOES, M. O., JÄGER, C., MITTELBRONN, M., SCHWAMBORN, J. C., CORDERO MALDONADO, M. L., CRAWFORD, A., SCHYMANSKI, E., & LINSTER, C. (2023). CLN3 deficiency leads to neurological and metabolic perturbations during early development. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/57737. doi:10.1101/2023.03.17.533107 |
HEINS MARROQUIN, U., JUNG, P., CORDERO MALDONADO, M. L., CRAWFORD, A., & LINSTER, C. (27 September 2019). Phenotypic assays in yeast and zebrafish reveal drugs that rescue ATP13A2 deficiency. Brain Communications, 1 (1), 2-17. doi:10.1093/braincomms/fcz019 Peer Reviewed verified by ORBi |
HEINS MARROQUIN, U. (2019). Modeling CLN3 and ATP13A2 deficiency in yeast and zebrafish and use of the ATP13A2 models for drug repurposing [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/40027 |
CORDERO MALDONADO, M. L., Perathoner, S., van der Kolk, K.-J., Boland, R., HEINS MARROQUIN, U., Spaink, H., Meijer, A.-M., Crawford, A., & de Sonneville, J. (2019). Deep learning image recognition enables efficient genome editing in zebrafish by automated injections. PLoS ONE. doi:10.1371/journal.pone.0202377 Peer Reviewed verified by ORBi |